Intralesional 5-fluorouracil Injection for the Treatment of Oral Leukoplakia
NCT05505539
·
clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Principal Investigator no longer with university.
Conditions
Oral Leukoplakia
Interventions
DRUG:
5-fluorouracil
Sponsor
University of California, San Francisco